Overview

Phase II Proof-of-concept Study of APD421

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
Evaluation of efficacy of APD421 in preventing nausea and vomiting caused by cisplatin
Phase:
Phase 2
Details
Lead Sponsor:
Acacia Pharma Ltd